104 related articles for article (PubMed ID: 15642529)
1. Comparison of selective ET(A) and ET(B) receptor antagonists in patients with chronic heart failure.
Cowburn PJ; Cleland JG; McDonagh TA; McArthur JD; Dargie HJ; Morton JJ
Eur J Heart Fail; 2005 Jan; 7(1):37-42. PubMed ID: 15642529
[TBL] [Abstract][Full Text] [Related]
2. Direct comparison of selective endothelin A and non-selective endothelin A/B receptor blockade in chronic heart failure.
Leslie SJ; Spratt JC; McKee SP; Strachan FE; Newby DE; Northridge DB; Denvir MA; Webb DJ
Heart; 2005 Jul; 91(7):914-9. PubMed ID: 15958361
[TBL] [Abstract][Full Text] [Related]
3. Endogenous endothelin in human coronary vascular function: differential contribution of endothelin receptor types A and B.
Halcox JP; Nour KR; Zalos G; Quyyumi AA
Hypertension; 2007 May; 49(5):1134-41. PubMed ID: 17353514
[TBL] [Abstract][Full Text] [Related]
4. Dual constrictor and dilator actions of ET(B) receptors in the rat renal microcirculation: interactions with ET(A) receptors.
Just A; Olson AJ; Arendshorst WJ
Am J Physiol Renal Physiol; 2004 Apr; 286(4):F660-8. PubMed ID: 14678950
[TBL] [Abstract][Full Text] [Related]
5. Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade.
Goddard J; Johnston NR; Hand MF; Cumming AD; Rabelink TJ; Rankin AJ; Webb DJ
Circulation; 2004 Mar; 109(9):1186-93. PubMed ID: 14981006
[TBL] [Abstract][Full Text] [Related]
6. Haemodynamic influence and endothelin-1 plasma concentrations by selective or non-selective endothelin receptor antagonists in the pig in vivo.
Holm P; Franco-Cereceda A
Acta Physiol Scand; 1999 Feb; 165(2):163-8. PubMed ID: 10090327
[TBL] [Abstract][Full Text] [Related]
7. Endothelin-1 contributes to maintenance of systemic but not portal haemodynamics in patients with early cirrhosis: a randomised controlled trial.
Tripathi D; Therapondos G; Ferguson JW; Newby DE; Webb DJ; Hayes PC
Gut; 2006 Sep; 55(9):1290-5. PubMed ID: 16434427
[TBL] [Abstract][Full Text] [Related]
8. Effects of antagonists for endothelin ET(A) and ET(B) receptors on coronary endothelial and myocardial function after ischemia-reperfusion in anesthetized goats.
Climent B; Fernández N; García-Villalón AL; Monge L; Sánchez A; Diéguez G
Vascul Pharmacol; 2006 May; 44(5):384-90. PubMed ID: 16580265
[TBL] [Abstract][Full Text] [Related]
9. Role of endothelin-1 receptor antagonists in vasoconstriction mediated by endothelin and other vasoconstrictors in human internal mammary artery.
He GW; Liu MH; Yang Q; Furnary A; Yim AP
Ann Thorac Surg; 2007 Nov; 84(5):1522-7. PubMed ID: 17954056
[TBL] [Abstract][Full Text] [Related]
10. Fractional urinary excretion of endothelin-1 is reduced by acute ETB receptor blockade.
Goddard J; Johnston NR; Cumming AD; Webb DJ
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1433-8. PubMed ID: 17855483
[TBL] [Abstract][Full Text] [Related]
11. Selective endothelin B receptor blockade does not influence BNP-induced natriuresis in man.
van der Zander K; Houben AJ; Webb DJ; Udo E; Kietselaer B; Hofstra L; De Mey JG; de Leeuw PW
Kidney Int; 2006 Mar; 69(5):864-8. PubMed ID: 16518347
[TBL] [Abstract][Full Text] [Related]
12. Altered peripheral vascular responses to exogenous and endogenous endothelin-1 in patients with well-compensated cirrhosis.
Helmy A; Jalan R; Newby DE; Johnston NR; Hayes PC; Webb DJ
Hepatology; 2001 Apr; 33(4):826-31. PubMed ID: 11283846
[TBL] [Abstract][Full Text] [Related]
13. Contribution of endothelin 1 to the vascular effects of diesel exhaust inhalation in humans.
Langrish JP; Lundbäck M; Mills NL; Johnston NR; Webb DJ; Sandström T; Blomberg A; Newby DE
Hypertension; 2009 Oct; 54(4):910-5. PubMed ID: 19687345
[TBL] [Abstract][Full Text] [Related]
14. The vascular endothelin system is not overactive in normotensive hemodialysis patients.
Büssemaker E; Passauer J; Reimann D; Schulze B; Reichel W; Gross P
Kidney Int; 2002 Sep; 62(3):940-8. PubMed ID: 12164876
[TBL] [Abstract][Full Text] [Related]
15. Endothelin-B-receptor-selective antagonist inhibits endothelin-1 induced potentiation on the vasoconstriction to noradrenaline and angiotensin II.
Gössl M; Mitchell A; Lerman A; Opazo Saez A; Schäfers RF; Erbel R; Philipp T; Wenzel RR
J Hypertens; 2004 Oct; 22(10):1909-16. PubMed ID: 15361762
[TBL] [Abstract][Full Text] [Related]
16. Enhanced endothelium-dependent vasodilatation by dual endothelin receptor blockade in individuals with insulin resistance.
Shemyakin A; Böhm F; Wagner H; Efendic S; Båvenholm P; Pernow J
J Cardiovasc Pharmacol; 2006 Mar; 47(3):385-90. PubMed ID: 16633080
[TBL] [Abstract][Full Text] [Related]
17. The effects of aging and exercise training on endothelin-1 vasoconstrictor responses in rat skeletal muscle arterioles.
Donato AJ; Lesniewski LA; Delp MD
Cardiovasc Res; 2005 May; 66(2):393-401. PubMed ID: 15820208
[TBL] [Abstract][Full Text] [Related]
18. A causal role for endothelin-1 in the vascular adaptation to skeletal muscle deconditioning in spinal cord injury.
Thijssen DH; Ellenkamp R; Kooijman M; Pickkers P; Rongen GA; Hopman MT; Smits P
Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):325-31. PubMed ID: 17122448
[TBL] [Abstract][Full Text] [Related]
19. Ethnic differences in the vasoconstrictor activity of endogenous endothelin-1 in hypertensive patients.
Campia U; Cardillo C; Panza JA
Circulation; 2004 Jun; 109(25):3191-5. PubMed ID: 15148269
[TBL] [Abstract][Full Text] [Related]
20. Coronary vasodilation and improvement in endothelial dysfunction with endothelin ET(A) receptor blockade.
Halcox JP; Nour KR; Zalos G; Quyyumi AA
Circ Res; 2001 Nov; 89(11):969-76. PubMed ID: 11717152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
